US6020457A - Disulfide-containing dendritic polymers - Google Patents
Disulfide-containing dendritic polymers Download PDFInfo
- Publication number
- US6020457A US6020457A US08/941,527 US94152797A US6020457A US 6020457 A US6020457 A US 6020457A US 94152797 A US94152797 A US 94152797A US 6020457 A US6020457 A US 6020457A
- Authority
- US
- United States
- Prior art keywords
- core
- dendritic polymer
- dendrimer
- dendritic
- disulfide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/16—Dendrimers and dendritic polymers
Definitions
- This invention relates to dendritic polymers.
- Dendritic polymers have been successfully incorporated as biological binding reagents in immunoassay systems, and have demonstrated assay performance, such as in radial partition immunoassay formats, which is equivalent or superior to systems incorporating conventional binding reagents such as polystyrene beads.
- the benefits which have been achieved by incorporating dendritic polymer binding reagents in immunoassay systems include increased assay sensitivity, greater precision, and reduced time required for analysis.
- the potential for successfully utilizing conventional dendritic polymers as biological binding reagents in certain biomedical or diagnostic applications is, to an extent, limited by the statistical distribution of different degrees of substitution found in dendritic polymer conjugates prepared by attachment of biological compounds to the surface groups of the dendritic polymer. In surface conjugations, different degrees of substitution and positional isomers may elicit different chemical and/or biological responses in certain applications and may yield unexceptably broad peaks or bands when subjected to separation techniques, such as chromatography or electrophoresis.
- PAMAM Differentiated polyamidoamine dendrimers having heterogenous surface-groups topologically confined in a fixed region on the surface with respect to each other have been prepared from a reactive initiator core reagent, such as dibenzyl amine, using conventional divergent synthesis techniques. After the desired generation of growth has been achieved, the surface amino groups of the PAMAM dendron are completely blocked by the addition of two alkyl epoxides per terminal amino group. The benzyl groups at the core are then cleaved by hydrogenation to generate a primary amino group, which can then act as an initiating site for growth of two additional PAMAM dendrons. The additional dendrons can be synthesized or grown to any desired generation and can be subsequently subjected to surface modifications to provide surface or terminal groups which are different from those of the first synthesized dendron having the alkyl functional groups.
- a reactive initiator core reagent such as dibenzyl amine
- Differentiated dendrimers have also been prepared by reacting a multiple functional anchoring core with a plurality of different dendrons prepared by divergent controlled synthesis involving iterative sequencing, upon a monoamine focal compound (e.g., an amino alcohol), of methacrylate and ethylene diamine according to the usual branch cell method used in preparing PAMAM type dendritic polymers.
- the dendrons can be individually synthesized to any desired generation and can be individually modified to provide any of various different types of functional groups (e.g., hydroxyl, mercapto, nitrile, amide, carboxylic, etc.) prior to being combined with the anchoring core.
- this first method cannot be used for preparing differentiated dendritic polymers having two different homogeneous sectors which each have reactive functional groups at the surface, or any other type of differentiated dendritic polymer which does not have a homogenous surface sector which is comprised of alkyl terminal groups.
- the second method of preparing differentiated dendrimers generally involves reacting dendrons having hydroxy focal groups with a multi-functional anchoring core, such as terephthaloyl chlorides, isophthaloyl chlorides or 1,3,5-benzene tricarbonyl chloride, in a volatile organic solvent, such as dichloromethane.
- a multi-functional anchoring core such as terephthaloyl chlorides, isophthaloyl chlorides or 1,3,5-benzene tricarbonyl chloride
- dichloromethane a volatile organic solvent
- Nano-sized films having a thickness from a few nanometers (a mono layer) to several hundred nanometers have been shown to be useful in various applications such as in optical devices, in electrical devices, catalyst systems, sensors, biosensors, and as biocompatable coatings.
- Nano-sized films have most commonly been prepared using the Langmuir-Blodgett (L-B) technique, in which multiple layered thin films are prepared by sequential transfer of monolayers from a water surface to a solid substrate.
- L-B technique has been recognized as being undesirable because of the relatively expensive apparatus required and because the method and apparatus are only capable of coating small support surfaces. L-B technique is also considered to be relatively difficult and complicated.
- the film is comprised of one or more layers made of organic materials (e.g., polyelectrolytes) which in each layer contain ions of the same charge, the ions of the first layer having the opposite charge of a modified support, and in the case of multiple layers, each further layer having the opposite charge of the previous layer.
- the method involves modifying a support so that the support carries ions or ionizable compounds of the same charge over the entire surface of the support, and applying one or more layers made of organic materials, the organic materials in each layer having ions of the same charge, the organic material being applied from a solution of the organic materials to the modified support.
- the organic materials forming the layers on the support have been limited to monomeric substances having two ionic or ionizable functional groups of the same charge or conventional linear polymers containing a plurality of ionic or ionizable functional groups, i.e., linear ionomers or polyelectrolytes.
- Ultrathin films formed by the method of applying ionic or ionizable monomeric or linear polymeric materials have certain disadvantages and limited applications. Because some of the functional groups of linear polyelectrolytes are buried inside of the polyelectrolyte, the resulting thin films formed using polyelectrolytes are not as strongly adsorbed onto the support surface as would otherwise be possible if all of the functional groups were available on the surface of the organic materials forming the layers of the ultrathin film. With conventional linear polyelectrolytes and monomeric electrolytes, it is not generally convenient to attach electrically, optically or biochemically active functional groups to the organic materials forming the layers of the ultrathin film prior to adsorption of these organic materials to the support surface.
- a further disadvantage with conventional ultrathin films is that they do not inherently include a first type of functional group which can be used for attachment to the support or an adjacent layer of the film and a second type of functional group which is available for subsequent adsorption or conjugation, such as with a biological compound.
- This invention pertains to dendritic polymers containing disulfide functional groups which are essentially inert until reduced to sulfhydryl groups, after which the sulfhydryl groups can be reacted with various compounds to form a variety of novel compounds having unique properties, characteristics and applications.
- FIG. 1 is a graph of ultraviolet absorbance versus number of layers for a multilayer film of polystyrenesulfonate and poly(allylamine hydrochloride);
- FIG. 3 is a nuclear magnetic resonance spectrum of the starburst dendrimer sample characterized by size exclusion chromatography in FIG. 2;
- FIG. 4 is a graph of ultraviolet absorbance versus number of layers for a multilayer film of polystyrenesulfonate and a generation 7, NH 3 core, polyamidoamine dendrimer;
- FIG. 5 is a graph of ultraviolet absorbance versus number of layers for a multilayer film comprising alternating polystyrenesulfonate and a generation 7, NH 3 core, polyamidoamine dendrimer on a uniform polystyrenesulfonate/poly(allylamine hydrochloride) multilayer surface;
- FIG. 6 is a reaction scheme showing the synthesis of a dendrimer-fluorescein derivative
- FIG. 7 is a graph of ultraviolet absorbance versus number of layers for a polystyrenesulfonate/polyamidoamine dendrimer (G7) multilayer film built on a uniform polystyrenesulfonate/poly(allylamine hydrochloride) multilayer precursor film;
- FIG. 8 shows a reaction scheme for the synthesis of a 2-sulfophenyl derivatized polyamidoamine dendrimer
- FIG. 9 is an ultraviolet spectrum of a 2-sulfophenyl derivatized polyamidoamine dendrimer
- FIG. 10 is a graph of ultraviolet absorbance versus number of layers for a multilayer film comprising alternating polyamidoamine dendrimer/polystyrenesulfonate layers built on a precursor film comprising alternating layers of polystyrene sulfonate and poly(allylamine hydrochloride);
- FIG. 11 is a size exclusion chromatograph of a cystamine core polyamidoamine dendrimer
- FIG. 12 is a nuclear magnetic resonance spectrum of the cystamine core polyamidoamine dendrimer characterized by size exclusion chromatography in FIG. 11;
- FIG. 13 is schematic representation of the reduction of a cystamine core polyamidoamine dendrimer layer using dithiothreitol
- FIG. 14 shows a comparison of ultraviolet adsorption spectra for a cystamine core polyamidoamine dendrimer incorporated into a multiple layer film before and after reduction with dithiothreitol;
- FIG. 15 is a graph of oscillator frequency versus time for a quartz crystal microbalance electrode onto which a cystamine core polyamidoamine dendrimer is being adsorbed from an ethanol solution;
- FIG. 16 is a graph of frequency versus time for a quartz crystal microbalance electrode onto which a cystarnine core polyamidoamine dendrimer is being adsorbed from an aqueous solution;
- FIG. 17 is a frequency-time plot of adsorption of a cystamine core polyamidoamine dendrimer onto a quartz crystal microbalance electrode at the same pH as in FIG. 16 (pH of 2.0), but with an externally applied potential of 500 mV across the electrodes;
- FIG. 18 is a frequency-time plot of adsorption of a cystamine core polyamidoamine dendrimer onto a quartz crystal microbalance electrode at a pH of 2.0, with an externally applied potential of -500 mV;
- FIG. 19 is a cyclic voltammetry graph of an electrochemical quartz crystal microbalance calibration standard comprising 0.1 M K 3 Fe(CN) 6 in a 0.1 M NaNO 3 aqueous solution;
- FIG. 20 is a graph of the quartz crystal microbalance frequency response of the cyclic voltammagram shown in FIG. 19;
- FIG. 21 shows the cyclic voltammetry results and the corresponding frequency changes associated with redox cycling of a preformed self-assembled cystamine core polyamidoamine dendrimer film adsorbed on the quartz crystal microbalance electrode from a buffered aqueous solution;
- FIG. 22 is a cyclic voltammetry results for the sample used in FIG. 21 scanned over a larger electrochemical potential range
- FIG. 23 shows the cyclic voltammetry results for the sample of FIGS. 21 and 22, but at a higher electrolyte concentration
- FIG. 24 shows the electrochemical quartz crystal microbalance result when a Cu(NO 3 ) 2 solution was added to the electrolyte in the presence of a dendrimer-modified electrode
- FIG. 25 shows the electrochemical quartz crystal microbalance voltammetry result when additional Cu(II) was added to the solution of FIG. 23;
- FIG. 26 shows the effects on the voltammetry results when the concentration of Cu(II) in the electrolyte solution and the chemical potential ranges are both further increased.
- dendritic polymers having a single disulfide functional group at the core are provided. These dendritic polymers having a single disulfide functional group at the core can be of generally any desired generation and can include any of a variety of different surface functional groups.
- the single disulfide group at the core can be reduced to form two sulfhydryl groups and split the dendritic polymer molecule into two parts, each having a single reactive sulfhydryl group to which other molecules, such as proteins, oligonucleotides, peptides, hormones, other dendritic polymers, non-dendritic (e.g., linear or branched) polymers, etc., can be bound.
- the remaining surface groups (which can, for example, be amines, carboxylates, hydroxyl, etc.) may be used for signal amplification, attachment to surfaces, analyte interaction, further conjugation, etc.
- dendritic polymers especially dendrimers of generally any generation, can be prepared having a very narrow molecular weight distribution, and hence a very narrow particle size distribution, and can be readily subjected to surface modification, it is possible to produce disulfide functionalized dendritic polymers having properties customized to provide optimum performance in a variety of specific applications.
- disulfide functionalized dendritic polymers include formation of differentiated dendrimers having heterogeneous surface-group topology confined in a fixed region on the surface, formation of ultrathin dendritic polymer-containing films for use in biological sensing devices, formation of binding reagents for diagnostics, drug delivery, gene therapy, and magnetic resonance imaging, and in the preparation of self-assembled dendritic monolayers on a quartz crystal resonator to provide dendritic polymer-modified electrodes useful for detecting various ions or molecules which can selectively bind to the dendrimer surface.
- dendritic polymers having sulfhydryl terminal or surface groups are provided.
- the sulfhydryl terminated dendritic polymers may be prepared by terminating a dendritic polymer with a compound containing a disulfide functional group and subsequently reducing the disulfide group or by reacting with a reagent that produces a free thio group (such as Traut's reagent).
- the dendritic polymers having terminals containing disulfide functional groups can be used to prepare stable, curable resin compositions which can undergo cross-linking when subjected to a relatively mild reducing agent and subsequent oxidation to form inter-molecular disulfide linkage.
- the dendritic polymers of this invention can, in general, be prepared using either of the well-known synthesis schemes, i.e., the convergent approach or the divergent approach. Any of the known reaction methods including the one-pot method, the protect-deprotect method, or the excess reagent method can be employed in the preparation of the dendritic polymers of this invention.
- the one-pot method tends to produce imperfect dendritic molecules having a relatively high polydispersity as compared to the nearly perfect dendrimers having a polydispersity near unity which can be prepared using the protect-deprotect method or excess reagent method.
- the resulting disulfide-functionalized dendritic polymers of this invention include generally any of the known dendritic architectures including, dendrimers, controlled hyperbranched polymers, dendrigrafts, and random hyperbranched polymers.
- dendrimers random hyperbranched polymers, controlled hyperbranched polymers and dendrigrafts are well-known. Methods of synthesizing dendrimers are set forth in U.S. Pat. Nos. 4,507,466; 4,558,120; 4,568,737; 4,587,329; 4,631,337; 4,694,064; 4,713,975; 4,737,550; 4,871,779 and 4,857,599. Examples of hyperbranched polymers and methods of preparing the same are set forth, for example in U.S. Pat. No. 5,418,301.
- the dendritic polymers of this invention are characterized by a relatively high degree of branching, which is defined as the number average fraction of branching groups per molecule, i.e., the ratio of terminal groups plus branch monomer units to the total number of terminal groups, branch monomer units and linear monomer units.
- degree of branching is one.
- degree of branching is zero.
- Hyperbranched polymers have a degree of branching which is intermediate that of linear polymers and ideal dendrimers. A degree of branching of at least about 0.5 is preferred.
- the dendritic polymers of this invention may also include macromolecules commonly referred to as cascade molecules, arborols, arborescent grafted molecules, and the like.
- dendritic polymers i.e., dendritic macromolecules linked together either through surface functional groups or through a linking molecule connecting surface functional groups together, and dendritic polymer aggregates.
- the dendritic polymers of this invention can be generationally monodisperse or generationally polydisperse.
- Dendritic polymers in a monodisperse solution are substantially all of the same generation, and hence of uniform size and shape.
- the dendritic polymers in the polydisperse solution comprise a distribution of different generation polymers.
- the dendritic polymers having a core containing a disulfide group will be illustrated in further detail with respect to the synthesis of polyamidoamine (PAMAM) dendrimers having a cystamine core using the excess reactant method for divergent dendritic synthesis.
- PAMAM polyamidoamine
- the principles of this invention are broadly applicable to generally all dendritic polymer types and synthesis techniques. The applicability of these principles will become readily apparent to those skilled in the art upon review of this disclosure.
- a core molecule having a disulfide moiety and a plurality of reactive terminal amino groups is reacted with an excess of methyl acrylate via a Michael addition reaction between the terminal amino groups on the core and the double bond on the methyl acrylate molecules to form a -0.5 generation PAMAM dendrimer having a plurality of carbomethoxy ester terminal groups.
- the zero generation and each successive half-generation is prepared in the usual manner by alternately separating the half-generation dendrimers from unreacted methyl acrylate and reacting the carboxy ester terminals with excess ethylene diamine to form the full-generation amino terminated dendrimers, and separating the full-generation dendrimers from unreacted ethylene diamine and reacting them again with excess methyl acrylate.
- Any desired generation of amino terminated, and any desired half-generation of carbomethoxy ester terminated PAMAM dendrimers having a core with a disulfide linkage can be obtained in this manner.
- the disulfide moiety-containing core molecule includes at least one amino group on each side of the disulfide moiety, and is preferably, but not necessarily, symmetrical with respect to the disulfide bond.
- Preferred core molecules for forming PAMAM type dendritic polymers having a disulfide bond at the core include diamines, with cystamine being presently preferred.
- the concepts of the present invention can be extended to other types of dendritic polymers having a disulfide-containing core by using different types of core reagents having a disulfide moiety but different reactive terminals or by modifying the amino terminals on the disulfide-group-containing polyamine compounds.
- cystamine can be reacted under appropriate conditions with acrylonitrile to form a molecule having four cyano terminal groups.
- the cyano-terminated molecule can then be hydrogenated to form a compound having four amino terminal groups.
- the above reactions can be repeated as desired to form half-generation poly (propyleneimine) dendrimers having cyano terminals or full-generation poly (propyleneimine) dendrimers having amino terminals.
- dendritic polymers can be prepared with a disulfide-containing core, using divergent or convergent synthesis schemes.
- Examples of dendritic polymers which can be prepared with a core containing a disulfide bond include polyether dendrons, dendrimers and hyperbranch polymers, polyester dendrons, dendrimers and hyperbranch polymers, polythioether dendrons, dendrimers and hyperbranch polymers, and polyarylalkylene dendritic polymers.
- the dendritic polymers having a disulfide moiety-containing core can be subjected to any of various well-known surface modification techniques to provide dendritic molecules having a single disulfide bond at the core which is reducible to split the molecule at the disulfide linkage to form two dendritic molecules having a single sulfhydryl functional group and a plurality of surface groups, which may be reactive or unreactive, as desired, and either hydrophilic or hydrophobic, as desired, etc.
- the dendritic polymers having a single disulfide bond at the core can be subjected to a relatively mild reducing agent such as dithiothreitol to split the polymer into two parts and generate a reactive sulfhydryl group on each part to form dendritic polymer molecules having a single sulfhydryl group which can be used as a distinct reactive point to which other molecules can be selectively attached, and a plurality of surface groups (such as amines) which can be used for purposes of signal amplification, attachment to surfaces, analyte interaction, further conjugation, etc.
- a relatively mild reducing agent such as dithiothreitol
- the single reactive functional group allows the design of well defined homogeneous conjugates which are unencumbered by the typical statistical distribution of different degrees of substitution found in conjugates prepared via the surface groups of dendrimer molecules.
- An advantage lies in the fact that a unique discrete conjugate is formed which has a narrow molecular weight distribution and, therefore, is not complicated by the potential of different bioreactivites.
- the homogenous conjugates of this invention are generally comprised of a dendritic polymer having a sulfhydryl group and a carried material conjugated to the dendritic polymer at the sulfhydryl group.
- Preferred carrier materials are generally bioactive agents.
- the dendritic polymers having a single disulfide group can be combined with different dendritic polymers also having a single disulfide group, reduced to form two different types of dendritic molecules, each of which has a single reactive sulfhydryl group, and reoxidized under aerobic conditions to form a mixture containing each of the original dendritic polymers and a differentiated dendritic polymer comprised of a part of each of the two original dendritic polymers.
- the dendritic polymers used to prepare the differentiated dendrimers can have different functional groups to produce differentiated dendrimers having a first type of functional group which is isolated to a first sector or surface area of the polymer, and a second type of functional group which is isolated to a second sector or surface area of the polymer.
- Such differentiated dendritic polymers can be used to prepare well defined complex conjugates wherein the first type of functional group on the differentiated dendritic polymer is used to selectively bind with a first type of molecule and a second type of functional group on the differentiated dendritic polymer which is used to selectively bind with a second, different type of molecule.
- the dendritic polymers of this invention can be used in the preparation of a thin film coated substrate including a substrate which has been modified by application of ions or ionizable compounds of the same charge over the surface of the substrate, and one or more layers of organic materials which in each layer contains ions of the same charge, the ions of the layer immediately adjacent the substrate having the opposite charge of the modified substrate, and in the case of further layers, each further layer having a charge opposite that of the previous layer.
- the general technique is disclosed in U.S. Pat. No. 5,208,111, which is incorporated by reference herein.
- the thin films of this invention incorporate at least one layer of a dendritic polymer.
- a cystamine core dendrimer with amino-terminal groups
- a cystamine core dendrimer layer By incorporating a cystamine core dendrimer layer into the film, it is possible to cleave the film at a precise location or thickness of the film by reducing the cystamine linkages with a mild reducing agent such as dithiothreitol.
- the sulfhydryl groups which are formed can then be reacted with targeting moieties, such as antibodies, enzymes or other proteins to create a unique sensing element.
- the disulfide-core-containing dendritic polymers of this invention can be used in the preparation of a self-assembled monolayer on a quartz crystal resonator to allow for the sensitive detection of mass buildup on the surface of the electrode.
- the disulfide linkage of the dendritic polymer can react with a gold surface of the electrode to form a self-assembled monolayer.
- These dendrimer-modified electrodes can be used to detect a variety of small molecules (for example, copper ions) or even larger biomolecules.
- Another aspect of this invention involves the preparation of dendritic polymers having branch groups, includes terminal groups, which include a disulfide moiety which is essentially inert under non-reducing conditions, but which can be subjected to a reducing agent to form a dendritic polymer having sulfhydryl terminal groups.
- terminal groups which include a disulfide moiety which is essentially inert under non-reducing conditions, but which can be subjected to a reducing agent to form a dendritic polymer having sulfhydryl terminal groups.
- an ethylene diamine core PAMAM dendrimer having methoxy carbonyl terminals e.g., a generation 1.5 ethylene diamine core PAMAM dendrimer
- a solvent such as methanol
- the cystamine-terminated dendrimer can be subjected to a reducing agent such as dithiothreitol to yield a sulfhydryl terminated dendrimer.
- a reducing agent such as dithiothreitol
- a cross-linked species is formed by reaction of the sulfhydryl groups of different dendritic molecules.
- a cystamine-terminated dendrimer such as that described above, can be reacted with methyl acrylate under appropriate conditions to form a PAMAM dendrimer having branch groups containing a disulfide moiety.
- the resulting methoxy carbonyl terminated dendrimer can be separated from any unreacted methyl acrylate and reacted with ethylene diamine to form an amine terminated PAMAM dendrimer having branch groups with a disulfide moiety. Any of the above steps can be repeated as desired to form dendritic polymers having one or more internal disulfide branch cell layers at any selected generation or radius from the core.
- Another approach to the synthesis of a dendrimer which contains sulfhydryl terminal groups is to react an amine-terminated dendrimer with iminothiolane (Traut's reagent).
- this thio modified dendrimer If this thio modified dendrimer is kept under reducing conditions, it maintains its solubility as shown by the clear, homogeneous solution that results. When oxygen is introduced to the solution, a gel forms, presumably due to the formation of disulfide bonds between the dendrimer molecules. This gel formation is reversible with the addition of an appropriate reducing agent.
- Such dendritic polymers are expected to have utility in biological sensing devices, as binding reagents for diagnostics, and in sophisticated drug delivery systems.
- Detection was performed at 230 nm via an ISCO V-4 detector.
- the first peak off of the column (the modified PAMAM) was collected, dried under nitrogen and reconstituted with 340 uL of 25 mM DTT.
- One uL of TEA was added and the reaction was incubated for 30 minutes at room temperature.
- the reaction mixture was then passed over an LH-20 column (vida supra) and the first peak was collected. This first peak was the reduced form of the dendrimer as evidenced by a colorimetric response from Ellman's reagent.
- the second peak off of the column yielded a negative response to Ellman's reagent and is excess TESPA-NHS which was not completely removed from the first pass over the column.
- the third peak is the large excess of dithiothreitol. This peak gave a positive response to Ellman's reagent.
- Unmodified cystamine-core PAMAM with amino groups on the surface appeared to adsorb to the LH-20 resin when methanol was used as the eluent. Apparently, these chromatographic conditions require a hydrophobic surface on the dendrimer for efficient elution of the compound.
- oligonucleotide moiety Preparation of oligonucleotide moiety.
- a 10 nmol quantity of a 17-mer oligonucleotide with a hexamethylene amine group on the 5'-end was placed in 15.4 ⁇ L of 50 mM borate buffer of pH 8.5.
- the oligonucleotide was treated with 0.6 mg sulfo-SIAB (Pierce Chemical Co.) in 200 ⁇ L of the same buffer.
- the reaction was incubated for two hors at room temperature in the dark and was then passed over a PD-10 Column with water as the eluent which was monitored at 260 nm.
- the first peak was collected, concentrated down to ca. 200 ⁇ L on a Centricon 10 (Amicon) unit and passed over the PD-10 column again.
- the SIAB-oligonucleotide was characterized by capillary gel electrophoresis (CGE).
- CGE capillary gel electrophoresis
- the migration time of the modified oligonucleotide was different than unmodified oligonucleotide as confirmed by coinjection experiments. All CGE experiments were preformed on a Beckman P/ACE 2050 equipped with System GoldTM software.
- Polyacrylamide gel-filled capillaries (5%T, 5%C, cat. no 193-5211) were obtained from J & W Scientific.
- J & W tris-borate-urea buffer (cat. no. 590-4001) was used in CE Experiments. Separations were performed in a 47 cm capillary with an injection to detector (UV detection at 254 nm) distance of 40 cm. Voltage was held constant at 300 V/cm.
- the reduced dendrimer in methanol (volume ca. 5 mL) was combined with the ca. 2 mL of the DNA-SIAB in water. The mixture was then taken to dryness on a rotoevaporator (30° C., ca. 1 in. Hg) and wasthen reconstituted with 750 ⁇ L methanol, 250 ⁇ L water, and 0.5 ⁇ L of triethanolamine (TEA). The pH of this reaction mixture was ca. 8. The reaction incubated at room temperature overnight in the dark.
- the crude reaction mixture was characterized by CGE; a new peak (the presumed conjugate) was observed in the electropherogram which had a different migration time than that of the oligonucleotide of the SIAB-modified oligonucleotide.
- the oligonucleotide peaks appear around 16 minutes when analyzed under the conditions described above whereas the presumed conjugate peak appears at ca. 19 minutes.
- Cystamine-core PAMAM dendrimer 150 ⁇ L of stock solution, 1.5 mg or 1.0 ⁇ mol was dissolved in 300 ⁇ L of a carbonate buffer (50 mM), containing 12.6 mg (or 21 ⁇ mol) of SCN-PA-DOTA (where SCN-PA-DOTA is an isothiocyanato derivative of ⁇ -[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). The mixture was adjusted to pH 9.5 with 2 N NaOH ( ⁇ 15 ⁇ L).
- the modified dendrimer (2.0 mL, ca. 200 nmol) was concentrated on a rotoevaporator to a volume of ca. 200 ⁇ L. This material was desalted on a PD-10 column and then evaporated to dryness and then reconstituted with 200 ⁇ L of carbonate buffer. The solution was adjusted to pH 8 with sodium bicarbonate (1.0M). A 200 ⁇ L aliquot of 50 mM DTT/5 mM EDTA in carbonate buffer (50 mM pH8) was added to the modified dendrimer. The reduction was conducted at 37° C. for 30 min., and the reduced material was purified by gel filtration on a PD-10 column.
- the reaction mixture was then passed over a PD-10 column and the appropriate column fractions were concentrated on Centricon 10 units and washed with five 2 mL washes of water to remove unconjugated dendrimer.
- the final retentate contained the presumed conjugate and had an OD 260 of 2.9 with a ⁇ max at 255 nm.
- the DOTA-C1-PAMAM-oligonucleotide conjugate was characterized by both polyacrylamide gel electrophoresis and by CGE. PAGE analysis supported formation of the conjugate as evidenced by a retarded migration distance of the presumed conjugate when compared to the unmodified oligonucleotide. Capillary electropherograms showed the presence of a presumed conjugate peak. Coninjection experiments of the conjugate with unmodified oligonucleotide and with the reduced dendrimer supported formation of the conjugate.
- the dendritic polymer-oligonucleotide conjugates can be advantageously employed in DNA analysis.
- the remaining (non-sulfhydryl) surface reactive groups on the dendritic can be used for signal amplification in various separation techniques such as electrophoreses and various chromatographic techniques.
- a 2 mg/mL solution of a generation three ethanolamine-terminated PAMAM dendrimer and a 0.5 mg/mL solution of a generation one ethylenediamine-terminated PAMAM dendrimer were prepared in a pH 8.2 borate buffer.
- the dendrimer concentrations are ca. 280 uM.
- One mL of each solution was withdrawn and mixed together.
- the samples were treated with 10 uL of a 0.21 M DTT solution in the same buffer, and the samples were incubated overnight and then ultrafiltered over a 500 molecular weight cutoff membrane in a micropartition device.
- Cystamine-core PAMAM dendrimers are useful for a single-point attachment of a dendritic PAMAM to another molecule in a conjugation scheme.
- the cystamine-core dendrimers are as easily synthesized as the more "conventional" ethylenediamine-core PAMAM dendrimers.
- the reduction (i.e., cleavage) of the dendrimer to yield a free sulfhydryl is relatively straightforward and can be done under mild reducing conditions.
- the reduced dendrimer can be purified by gel filtration or ultrafiltration to remove excess reductant.
- the sulfhydryl of a generation one material was found to be reactive toward Ellman's reagent and toward an iodoacetamide group on a 17 mer oligonucleotide.
- a reduced generation one cystamine-core PAMAM was also coupled to a reduced generation three cystamine-core PAMAM to yield a heterodisulfide in which the two hemispheres were of different sizes and also had different surface groups on each hemisphere.
- the single point of attachment on the reduced cystamine-core PAMAM provides a location for site-specific coupling of molecules to PAMAM dendrimers which still exhibit multiple surface groups for further conjugation or intermolecular interactions with other species.
- Such conjugates are monodisperse relative to conjugations performed on the multiple surface groups of dendrimers which are polydisperse owing to different degrees of substitution. The latter can only be made monodisperse by saturating the entire surface with a tag. Saturation however may be hindered when factors such as spatial constraint are considered.
- Poly (sodium 4-styrenesulfonate) NaPSS, MW ⁇ 70,000), poly(allylamine hydrochloride) (PAA HCl, high MW), 3-aminopropyltrimethoxysilane, 2-sulfobenzoic acid cyclic anhydride were purchased from Aldrich.
- 5-([4,6-Dichlorotriazin-2-yl]amino)fluorescein (DTAF) was obtained from Sigma.
- the construction of alternating polyelectrolyte multilayers was monitored by UVIVis spectroscopy (Cary Model 118 Spectrophotometer).
- the ultrapure water was obtained from Milli Q water purification system (18 M ⁇ cm).
- the toluene was distilled from CaH 2 .
- Aminopropylsilanized fused quartz, silicon wafer and Mica substrates were used for most of the experiments. Such substrates were ultrasonically activated in conc. H 2 SO 4 /H 2 O 2 (7:3) mixture at 50° C. for 1 hour and then rinsed with Milli Q water. After being consecutively immersed for 2 minutes in pure methanol, methanol/toluene (1:1) mixture, and pure toluene, these substrates were allowed to react with 3-aminopropyltrimethoxysilane (a 5% solution in toluene) for 15 hours under N 2 . The modified substrates were cleaned for 1 minute each in toluene, toluene/methanol (1:1) mixture methanol and then Milli Q water. The freshly amino-modified substrates were stored in water and used within 2 days.
- ultrathin multilayers were accomplished by consecutive adsorption from oppositely charged polyelectrolyte solutions.
- the amino-modified substrates were immersed for 20 minutes in a solution containing 40 mg NaPSS dissolved in a mixture of 1 ml of 0.1 N HCl and 19 ml of Milli Q water. After rinsing with water for 3 times, the substrates were then immersed for 20 minutes in a solution containing 40 mg PAA HCl in a mixture of 1 ml of 0.1 N HCl and 19 ml of Milli Q water.
- the ultrathin multilayer films were obtained.
- PAA HCl was replaced by protonated (NH 3 +) Starburst® dendrimers, while in another case dendrimer surfaces derivatized with sulfonate groups (SO 3 -) and the protonated dendrimer (NH 3 +) were used to build up multilayers comprised of only dendrimers.
- the quartz glass was ultrasonically activated in H 2 SO 4 /H 2 O mixture for 1 hour, washed with 30% of NaOH solution, and then rinsed with Milli Q water 3 times. The control experiment was done without washing with the NaOH solution.
- the dendrimer-NH 2 INaPSS multilayers were constructed on top of a PAA/NaPSS multilayer film at several different pH values (pH 7.5, 4.35, and 2.07).
- the dipping time in each oppositely charged solution was 5 minutes.
- Cystamine core dendrimer (Cys-G6.0) was synthesized as reported previously. The sample purity was checked by 13 C NMR, SEC, and IR. Cys-G6.0 was adsorbed from acidic solution onto a PAAH/NaPSS multilayer precursor film using a 20 min. dipping time. Such a film was subsequently constructed with either an additional 3, 4, or 21 PAAH/NaPSS bilayers. The reduction of cys-G6.0 within the multilayers was achieved in dithiothreitol solution (40 mg/20 ml water) at pH 8 (adjusted by NaHCO 3 ) for 2 hours. The control experiment was done under the same condition without dithiothreitol.
- the NaPSS/G7-1 DTAF multilayers were built on an uniform NaPSS/PAA HCl multilayer precursor film. Linear dependence of absorbance versus number of layers was obtained (FIG. 7). Under the same condition, the NaPSS/G7-10 DTAF multilayer films can also be constructed in a similar manner. However, no significant changes in slopes was observed. The reason will be discussed later. It has to be noted that the broken lines (jumps in the data) is due to the limitation of our UV spectrometer (baseline correction), rather than the polyelectrolyte film itself. Since without the baseline correction (when the instrument was stable), no significant changes in UV absorbance was observed no matter how long the film was stored.
- the quartz glass was directly cleaned with both acid and base solutions. It was found that a uniform polyelectrolyte multilayer thin film could be constructed on this substrate after about 5 NaPSS/PAAH bilayers. Although such a surface does not adsorb as many polyelectrolyte chains as the amino-modified surface, it provides a convenient way to clean the glass surface.
- the above results suggest that the quartz glass cleaned by a NaOH/EtOH solution (high basicity) could also be used directly for the construction of multilayer films.
- Cystamine core dendrimer was synthesized as reported previously. The sample purity was checked by 13 C NMR and SEC (FIGS. 11 and 12). A single cystamine core dendrimer layer was constructed onto a PAAH/NaPSS multilayer film, and then covered with more PAAH/NaPSS multilayers (Table I).
- the successful reduction of the cystamine core dendrimer layer at low coverage opens new applications in biomedical area.
- most of the currently used immunoassays are based on double antibody layers.
- the first antibody layer is used as a biocompatible layer in order to increase the assay sensitivity, while the second antibody layer is served as molecular recognition sites for the assay test.
- the first antibody layer could be replaced by a biocompatible dendrimer precursor layer.
- the difficult part is to attach the second antibody onto the dendrimer film without denaturing the proteins or enzymes.
- a mercapto (--SH) monolayer would be formed on top of the dendrimer thin film, and the second antibodies could then be attached conveniently under the mild biological conditions.
- Biosensors which comprised of an enzyme layer, could also be constructed in a similar manner. The advantage of this technique is that no separation procedures were involved and the bioconjugation could be directly achieved onto the solid surface.
- ultrathin dendrimer films could also be utilized in optical and electrical devices.
- the photo chromophores could be constructed through either S-S bond formation, ionic interactions, or covalently linked prior to adsorption.
- the resulting monolayer chromophore thin film may find applications in photo refractive index change, NLO, and wave guide.
- the Quartz Crystal Microbalance (QCM) instruments from two manufactures were used in this study.
- the other was the electrochemical quartz crystal nanobalance, EQCN-600 from ELCHEM, Postdam, NY 13676. Both models have the capability to do electrochemical measurements in a fast mode.
- the QCA917 model has a sample period of 0.1 to 10 second, while the EQCN-600 model has a sample period of 1 to 10 second.
- the QCM unit was controlled by an IBM PC 486 computer through a 16 bit data acquisition card.
- the data collection for EQCM are automatic. Because of the data storage limitation of the software, the data collections for long time kinetic experiments were carried out manually.
- the calculated sensitivity of a 10 MHz AT cut quartz crystal operating in the fundamental resonant frequency mode is about 0.88 ng/cm 2 with an accuracy of 0.1 ng.
- the operating temperature was ambient without further control. The accuracy of the frequency measurements were not significantly effected by changes in the ambient temperature.
- the gold electrode was mounted horizontally in the experimental cell with two electrodes connected to the oscillator. During the EQCM experiments, only one side of electrode was exposed to electrolyte solution.
- the gold coated AT cut quartz crystal was used as the working electrode and also as the frequency probe.
- the crystals were obtained either from International Crystal Manufacturing, Inc., Oklahoma City, or from EG&G PAR in an unpolished form.
- the gold coating layer, on both sides of the crystal, was about 3000 ⁇ which was deposited on top of a 200 ⁇ thick of titanium underlayer.
- the reference electrode was a saturated calomel electrode (SCE).
- the counter electrode was a platinum wire electrode.
- the gold electrode was washed with deionized water, repeatedly with absolute ethanol, and then stored in deionized water. The gold electrode was rinsed with water or ethanol prior to the EQCM experiments.
- Potassium nitrate 99.99+%, is obtained from Aldrich Chemical, Lot #12922PF, and was used without further purification.
- Anhydrous sodium perchlorate was obtained from Alfa/AESAR, Johnson Matthey, Lot #K12B35, and was used without further purification.
- Ferrocene was obtained from Aldrich Chemical, Lot #11213TF. This compound was purified by twice recrystallation from ethanol.
- Anhydrous methyl alcohol was obtained from Aldrich Chemical, Lot #32288EF, and was used without further purification.
- Potassium ferricyanide, 99.0+% was obtained from Aldrich Chemical, Lot #08225HZ, and was used without further purification.
- Octadecyl mercaptan 98% purity, was obtained from Aldrich Chemical, Lot #0937AF, and was used as received.
- QCM quartz crystal microbalance
- the basic principle of QCM is that an alternating electric field applied across a piezoelectric material, such as quartz crystal, induces a shear stress in that material.
- the vibration frequency of this shear stress of the quartz crystal is in the megahertz region. Therefore the changes in mass of the adsorbates on the surface of the piezoelectric quartz oscillator can be monitored by the changes in the vibrational resonance frequency of the oscillator.
- QCM is extremely sensitive to the presence of the surface-confined adsorbates.
- FIG. 15 shows the adsorption result for cystamine core PAMAM dendrimer (G0) in ethanol solution onto the gold-coated surface of the QCM electrode.
- the frequency response is typical of that seen for the self-assembly of long chain thiols and disulfides onto a gold surface.
- the frequency changes should correlate to the mass change resulting from the covalent linking of dithio moiety or mercaptan group to the gold surface.
- FIG. 15 shows one of the strong features of QCM, that is the real time, quantitative monitoring the mass change at the electrode surface is possible.
- the frequency gradually reached a plateau value after about three hours, which indicated a relatively fast assembly process of disulfide linkage of the G0 dendrimer on to the surface of the gold substrate.
- the equilibrium process normally required more than ten hours in organic solvents. As shown later in this report, this adsorption process could be accelerated by changing solvent from ethanol to an aqueous solution.
- the frequency change shown in FIG. 15 is on the order of 168 Hz, which corresponds to the mass change of 16.8 ng on the surface of the electrode.
- the surface coverage of dendrimer molecules on this quartz crystal should be of 2.93 ⁇ 10 -11 mole resulting in a mass changes for ideal monolayer adsorption is on the order of 17.8 ng. This value is in fairly good agreement with the experimental observation. Therefore, the experiment data for the adsorption of cystamine core G0 dendrimer onto the gold surface from an ethanol solution indicates that the dendrimers self-assemble into a closed, tight packed state. Apparently, this low generation dendrimer can pack onto the gold surface with very little inhibition due to steric congestion. Also control experiments were run with dendrimer that were made from nonreactive EDA core rather than reactive cystamine core molecule and these dendrimers showed no significant adsorption to the gold electrodes.
- FIG. 16 shows the frequency change associated with the absorption of cystamine core PAMAM dendrimer G0 onto a gold surface from an aqueous solution.
- concentration of dendrimer was about 4 ⁇ 10 -5 M, and as in the previous experiment, no bias potential applied across the electrodes.
- the aqueous solution was buffered to a pH of 2.0 with H 3 PO 4 .
- the frequency change observed due to the adsorption of dendrimer onto the gold substrate was on the order of 8790 Hz, which corresponds to a mass change of 87.9 ng. This mass increase was significantly larger than the ideal monolayer coverage on the gold substrate that was discussed above. We have two explanations for the increase of mass on the surface at the lower pH.
- the multilayer absorption of dendrimer can be explained by the strong interaction, primarily through hydrogen bonding, between the dendrimer molecules in acidic conditions. This interaction favored equilibrium of the dendrimer-gold assembly towards the surface region.
- the pH of aqueous solution partially charged some of the amine functional groups of dendrimer molecules. This was a very important aspect since it could have a concentration effect of making more dendrimer molecules onto the aggregates state which favor the multilayer formation.
- FIG. 17 shows the frequency-time plot of adsorption of cystamine dendrimer onto a gold substrate at the same concentration and pH in the previous experiment but this time an external applied potential of 500 mV was applied across the electrodes.
- the frequency change associated with the adsorption process decreased dramatically in comparison to the adsorption results obtained for both the non-biased experiment in water and also the ideal adsorption case from ethanol.
- the frequency change was on the order of 900 Hz, which translates into the mass increase of 9.0 ng on the quartz crystal. This mass increase is only about half of that for the ideal dendrimer monolayer coverage of the gold substrate.
- FIG. 17 Another interesting point of FIG. 17 was that the adsorption kinetics was faster than that of the previous case, i.e., the non-biased adsorption in aqueous solution or in ethanol solution. This is reasonable in the light of the electrostatic interactions between the partially charged dendrimer species and the gold surface. It is the same charge presence block further interaction after the initial chemsorption of cystamine dendrimer molecules. If this is true, then when negative external biased potential was applied into the same solution, the adsorption of cystamine dendrimer molecules onto the gold substrate surface should be more favored in both kinetic and thermodynamic terms.
- the first frequency decrease was an adsorption of cystamine core dendrimer molecules onto the gold surface which as accelerated by driving the positively charged dendrimers to the electrode with the presence of the negative applied electric field.
- the second, slower process was attributed to the electrochemically-driven desorption of the chemisorbed dendrimer molecules in the formed multilayer back to aqueous solution.
- This reductive process which was influenced by the negative applied potential, usually came with the increase of frequency. This has been previously reported by several groups in studies of the electrochemically-driven desorption of self-assembled, long chain thiol monolayers on gold electrode surface.
- the QCM and EQCM experiments are very powerful in studying the adsorption process of cystamine PAMAM dendrimer onto the gold surface.
- the solvent has strong effect on both kinetics and final self-assembly states.
- the adsorption process is slow but the final equilibrium state is close to perfect monolayer.
- the self-assembly adsorption process of dendrimer is more rapid but a multilayer film forms at the equilibrium state.
- the first study concerned the electrochemical stability of the dendrimer coated gold electrode surface in a pH buffered electrolyte solution.
- the second part focused on the incorporation of metal ions, copper(II), into the self-assembled dendrimer films.
- the frequency response measured from QCM was not clear enough to give meaningful results. This is mostly due to the high noise level involved in the experiments. Plausible causes are provided.
- the EQCM calibration experiments were performed with 0.1 M K 3 Fe(CN) 6 in 0.1 M NaNO 3 aqueous solution.
- the solution was buffered to pH of 2.0 either by HCl or HNO3.
- the cyclic voltammetry results are shown in FIG. 19.
- the scan rate was 100 mV/s, and two cycles of the potential scan were typically run.
- the potentials were referenced to SCE.
- the cyclic voltammetry curve was symmetric, but was not totally reversible in the case of fast scan rate. This may be due to the small area of gold electrode surface which can have some slow down effects on the cyclic volumetric scanning.
- the QCM frequency response of the cyclic voltammetry is shown in FIG. 20.
- FIG. 21 shows that the cyclic voltammetry results and the corresponding frequency changes associated with the redox cycling of the preformed self-assembled cystamine PAMAM dendrimer film in pH buffered aqueous solution in EQCM experiments.
- the supporting electrolyte was 10 -4 M NaNO 3 .
- the CV voltamagram clearly shows that the surface bounded G0 cystamine dendrimer molecules block the charge transport from the solution phase to the electrode surface. Similar ill-defined CV patterns has been previously observed during the electrochemical studies of self-assembled long chain thiol monolayers in both organic or aqueous media. Since the charge transport was slow and the signal/noise ration of QCM was also low, the current-potential graph was broad. Due to the low concentration of electrolyte in this experiment we were not able to differentiate whether charge transport was being limited by the coating of dendrimer onto the surface of gold electrode.
- the frequency response was obstructed by the low S/N ratio. Therefore the mass change associated with the redox process was not clearly defined. This could be due to two possible mechanisms.
- the first mechanism involves the limited charge transfer through the multilayer of dendrimer attached to the surface of gold electrode. This limited charge transfer through the self-assembled monolayer results in a frequency response which could not be clearly seen.
- the kinetics of dendrimer molecular species attaching to or coming off from the gold electrode surface was much slower than the charge transfer rate, so the frequency changes could not be shown under this condition.
- the second rationalization was the large chunk of physically adsorbed dendrimer molecules moved together as one species, such as an aggregate, which induced the high S/N ratio in the cyclic voltammetric process.
- FIG. 22 shows that the same sample scanned over a larger electrochemical potential range. Please note that the scale was different.
- the cyclic voltamagram diagram shows similar behavior as is seen in FIG. 21.
- the electrolyte concentration was low so that the charge transfer rate was very small.
- This system was stable up to 800 mV with the scan rate of 100 mV/s.
- the electrode was not scanned over the reduction potential range since it has been known that the sulfur-gold bond could be broken by applying high external potential. Therefore our EQCM studies were focused on the oxidation potential ranges.
- the second peak was observed as a relatively broader peak also centered around 300 mV.
- This extra oxidation peak could be attributed to the oxidation of amino functional groups of the cystamine dendrimer molecules.
- the position of the sharp peak was shifted to lower value. This could be due to the chelating of metal ion into the amino groups of dendrimer.
- the charge migration through the strong binding Cu(II) ion and the oxidation state of amino group was lowered by this stabilization.
- the high value of current shown in the same figure was explained by the facilitation charge transfer process of incorporated Cu(II) complex. As expected, no changes in mass were observed during the collection of the date for the CV of the dendrimer-copper complexes.
- the Cu(II) ion could be deposited on top of the gold electrode when the applied potential was negative enough.
- a small feature in the scan indicates a new reductive process taking place occurring around 0 V versus SCE.
- This feature has a corresponding feature seen during the scan in the oxidative direction.
- the first oxidation observed during the first scan increased in intensity during the second scan.
- the second scan showed that there were some free copper ions besides the bound Cu(II) either in the solution or close to the surface of gold electrode after a full cycle of oxidation and reduction.
- Cu(II) ions generated by electrochemical means free of any amino functional groups binding can exist in the aqueous solution. Therefore dendrimer electrochemical analysis can detect different states of a metal ion. Also, the tailing during the reductive scan is not associated with degradation of the self-assembled dendrimer film, since no mass loss was observed by the QCM.
- a 5 mg quantity (in 137 ⁇ L of water) of generation five ethylene diamine-core PAMAM dendrimer is placed in 863 ⁇ L of 50 mM borate buffer of pH 8.5.
- a 12 mg quantity of 2-iminothiolane (Traut's reagent) dissolved in 200 ⁇ L of the same buffer is added to the dendrimer solution.
- Incubation is conducted at room temperature, after which, the reaction mixture is passed over a 1 ⁇ 30 cm G-25 Sephadex column equilibrated with water.
- the column is connected to an ISCO V-4 detector set at 230 nm.
- the first peak is collected, concentrated to less than 500 ⁇ L on Centricon 30 units, and passed over the same column again.
- the first peak is collected (approx.
- the 4 mL of dendrimer solution was split into two equal halves. One was treated with 1 ⁇ L of triethanolamine (TEA), shaken with headspace atmospheric air for 1 h, and evaporated to dryness on a rotoevaporator. The resultant white solid was resuspended in water. Even after vigorous prolonged shaking, the solid would not dissolve. The other half of the sulfhydryl-modified dendrimer was also subjected to the same treatment. After resuspension in water, the solid was treated with approx. 10 mg of dithiothreitol. The white solid became translucent after several minutes of shaking and completely dissolved after 5 minutes of vigorous shaking.
- TAA triethanolamine
- the thiol modified dendrimer which was submitted to aerobic oxidation with atmospheric oxygen appeared to crosslink and form a water insoluble gel.
- the interdendrimer linkages are likely to be composed of disulfide bridges, thereby forming a gel network composed of dendrimers. Since the gel crosslinks are composed of disulfides, they can easily be reduced under mild conditions with a reductant such as dithiothreitol. Treatment of the dendrimer gel with dithiothreitol does cause dissolution and thereby exhibits an example of a redox reversible gel composed of dendritic molecules.
- Such gels may find application in fields such as drug delivery where a solid (the dendrimer gel) with a binding capacity for guests (e.g., a therapeutic drug bound within the interior of an individual dendrimer) can be deposited in a specific location in the patient. Endogenous biological reductants may gradually dissolve the dendrimer gel, thereby allowing escape of soluble dendrimer from the insoluble matrix.
- the soluble dendrimer component can either release the drug in a second time release or act as a carrier to deliver the drug to specific targets.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
TABLE I __________________________________________________________________________ Reduction of the Cystamine Core Dendrimer Layer as Monitored by UV. Silicon Wafer Precursor NaPSS/PAAH DTT or DTT and Time Surface (# of Bilayers) Cys-NH.sub.3 + (# of Bilayers) NaHCO.sub.3 NaHCO.sub.3 (hours) __________________________________________________________________________ --NH.sub.4 + >10 G6.0 3 X √ 2 SiO.sup.- >10 G6.0 4 X √ 2 SiO.sup.- >10 G6.0 21X X 24 __________________________________________________________________________ X: Reduction is not successful. √: Reduction is successful.
Claims (49)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/941,527 US6020457A (en) | 1996-09-30 | 1997-09-30 | Disulfide-containing dendritic polymers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2473496P | 1996-09-30 | 1996-09-30 | |
US08/941,527 US6020457A (en) | 1996-09-30 | 1997-09-30 | Disulfide-containing dendritic polymers |
Publications (1)
Publication Number | Publication Date |
---|---|
US6020457A true US6020457A (en) | 2000-02-01 |
Family
ID=26698805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/941,527 Expired - Lifetime US6020457A (en) | 1996-09-30 | 1997-09-30 | Disulfide-containing dendritic polymers |
Country Status (1)
Country | Link |
---|---|
US (1) | US6020457A (en) |
Cited By (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020025529A1 (en) * | 1999-06-28 | 2002-02-28 | Stephen Quake | Methods and apparatus for analyzing polynucleotide sequences |
US6432423B1 (en) * | 1997-12-19 | 2002-08-13 | L'oreal | Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
WO2002067908A1 (en) * | 2001-02-26 | 2002-09-06 | Duke University | Novel dendritic polymers and their biomedical uses |
WO2002072892A1 (en) * | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
US6475495B1 (en) * | 1997-12-19 | 2002-11-05 | L'oreal, S.A. | Hyperbranched polymers or dendrimers containing a particular group, preparation process, use and compositions comprising them |
US20030082103A1 (en) * | 2000-10-11 | 2003-05-01 | Targesome, Inc. | Targeted therapeutic lipid constructs having cell surface targets |
US20030119208A1 (en) * | 2001-12-04 | 2003-06-26 | Yoon Hyun Chul | Electrochemical immunosensor and kit and method for detecting biochemical anylyte using the sensor |
US20030129223A1 (en) * | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
US20030133972A1 (en) * | 2000-10-11 | 2003-07-17 | Targesome, Inc. | Targeted multivalent macromolecules |
US6617040B2 (en) | 2002-01-16 | 2003-09-09 | The United States Of America As Represented By The Secretary Of The Navy | Chemoselective dendrimeric compounds for use in chemical sensors |
US20030183578A1 (en) * | 2000-07-28 | 2003-10-02 | Kim Yung K. | Silicone derivatized macromolecules |
WO2003089106A2 (en) | 2002-04-16 | 2003-10-30 | Diazem Corporation | Multi-layered macromolecules and methods for their use |
US20040009495A1 (en) * | 2001-12-07 | 2004-01-15 | Whitehead Institute For Biomedical Research | Methods and products related to drug screening using gene expression patterns |
US20040020576A1 (en) * | 2000-08-03 | 2004-02-05 | The Goodyear Tire & Rubber Company | Pneumatic tire having a rubber component containing a dendrimer |
WO2004020504A1 (en) * | 2002-08-29 | 2004-03-11 | Isis Innovation Limited | Blended dendrimers |
US20040063158A1 (en) * | 2002-09-26 | 2004-04-01 | Ivan Alferiev | Method of determining surface binding capacity |
US6733883B2 (en) | 2002-09-18 | 2004-05-11 | The Trustees Of The University Of Pennsylvania | Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
US20040131582A1 (en) * | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
US20040146918A1 (en) * | 2000-02-18 | 2004-07-29 | Weiner Michael L. | Hybrid nucleic acid assembly |
US6773928B1 (en) * | 1999-09-22 | 2004-08-10 | The United States Of America As Represented By The Secretary Of The Army | Compositions and methods for enhancing bioassay performance |
US20040258614A1 (en) * | 2003-06-20 | 2004-12-23 | University Of Maryland, Baltimore | Microparticles for microarterial imaging and radiotherapy |
US20050032076A1 (en) * | 1998-05-01 | 2005-02-10 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
WO2005029539A3 (en) * | 2003-07-21 | 2005-05-06 | Dendritic Nanotechnologies Inc | Stabilized and chemically functionalized nanoparticles |
US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
US20050239085A1 (en) * | 2004-04-23 | 2005-10-27 | Buzby Philip R | Methods for nucleic acid sequence determination |
US20050260609A1 (en) * | 2004-05-24 | 2005-11-24 | Lapidus Stanley N | Methods and devices for sequencing nucleic acids |
US20060019276A1 (en) * | 2004-05-25 | 2006-01-26 | Timothy Harris | Methods and devices for nucleic acid sequence determination |
US20060019263A1 (en) * | 1999-06-28 | 2006-01-26 | Stephen Quake | Methods and apparatuses for analyzing polynucleotide sequences |
US20060024678A1 (en) * | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
US20060041058A1 (en) * | 2003-11-21 | 2006-02-23 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US20060046258A1 (en) * | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
US20060078927A1 (en) * | 2004-03-29 | 2006-04-13 | Peck Bill J | Methods for in situ generation of nucleic acid molecules |
US20060088499A1 (en) * | 2004-07-01 | 2006-04-27 | Virgil Percec | Amphiphilic dendritic dipeptides & their self-assembly into helical pores |
US20060118754A1 (en) * | 2004-12-08 | 2006-06-08 | Lapen Daniel C | Stabilizing a polyelectrolyte multilayer |
US20060172408A1 (en) * | 2003-12-01 | 2006-08-03 | Quake Steven R | Device for immobilizing chemical and biochemical species and methods of using same |
US20060172328A1 (en) * | 2005-01-05 | 2006-08-03 | Buzby Philip R | Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction |
US20060172313A1 (en) * | 2005-01-28 | 2006-08-03 | Buzby Philip R | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
US20060217525A1 (en) * | 2004-12-22 | 2006-09-28 | Wright Davis Biomedical Technologies, Inc. | Degradable polymers and methods of preparation thereof |
US20060216265A1 (en) * | 2002-07-19 | 2006-09-28 | The Regents Of The University Of California | Dendrimers as molecular translocators |
US20060223195A1 (en) * | 2004-11-16 | 2006-10-05 | Meyer Grant D | Stress based removal of nonspecific binding from surfaces |
US20060252077A1 (en) * | 2004-12-30 | 2006-11-09 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
US20060263790A1 (en) * | 2005-05-20 | 2006-11-23 | Timothy Harris | Methods for improving fidelity in a nucleic acid synthesis reaction |
US20070117103A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070117102A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070117104A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070128614A1 (en) * | 2005-12-06 | 2007-06-07 | Liu David R | Nucleotide analogs |
US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
KR100745833B1 (en) | 2006-03-06 | 2007-08-02 | 고려대학교 산학협력단 | Complex composition of cationic gold nanoparticles and dna for effective transfection |
WO2006105043A3 (en) * | 2005-03-28 | 2007-10-04 | Dendritic Nanotechnologies Inc | Janus dendrimers and dendrons |
US20070232770A1 (en) * | 2006-04-04 | 2007-10-04 | Jacobson Stephen E | Hyperbranched maleic anhydride-diene polymers |
US20070226915A1 (en) * | 2006-04-04 | 2007-10-04 | Jacobson Stephen E | Stain resist comprising hyperbranched maleic anhydride-diene polymers |
US20080020043A1 (en) * | 2006-07-20 | 2008-01-24 | Marc Gingras | Dendrimer-Drug Conjugates |
US20080114077A1 (en) * | 2005-03-21 | 2008-05-15 | Anp Technologies, Inc. | Symmetrically Branched Polymer Conjugates and Microarray Assays |
US20080152661A1 (en) * | 2006-08-18 | 2008-06-26 | Rozema David B | Polyconjugates for In Vivo Delivery of Polynucleotides |
US20080200562A1 (en) * | 2005-05-02 | 2008-08-21 | Anp Technologies | Polymer Conjugate Enhanced Bioassays |
US20080281074A1 (en) * | 1999-06-07 | 2008-11-13 | Rozema David B | Compounds and Methods for Reversible Modification of Biologically Active Molecules |
US20080281041A1 (en) * | 1999-06-07 | 2008-11-13 | Rozema David B | Reversibly Masked Polymers |
US20080287628A1 (en) * | 2002-03-11 | 2008-11-20 | Rozema David B | Endosomolytic Poly(Vinyl Ether) Polymers |
US20090048410A1 (en) * | 2002-03-11 | 2009-02-19 | Wakefield Darren H | Membrane Active Heteropolymers |
US20090299003A1 (en) * | 2008-05-29 | 2009-12-03 | Hawker Craig J | Highly efficient agents for dispersion of nanoparticles in matrix materials |
US20100028445A1 (en) * | 2006-09-29 | 2010-02-04 | The University Of Nottingham | Polymer |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
WO2010033137A1 (en) * | 2008-09-19 | 2010-03-25 | Trustees Of Boston University | Polymeric biolubricants for medical use |
US20100105857A1 (en) * | 2006-10-16 | 2010-04-29 | Gary Gellerman | Dendrimeric platform for controlled release of drugs |
US20100113559A1 (en) * | 2007-01-05 | 2010-05-06 | Biopolymed Inc. | Chitosan Based Polymer Conjugate and a Method for Producing the Same |
US7897345B2 (en) | 2003-11-12 | 2011-03-01 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US20110111951A1 (en) * | 2007-08-27 | 2011-05-12 | Valspar Sourcing, Inc. | Dendritic Oxygen Scavenging Polymer |
WO2011065916A1 (en) * | 2009-11-24 | 2011-06-03 | Agency For Science, Technology And Research | Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel |
US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
US20110183321A1 (en) * | 1998-05-01 | 2011-07-28 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
US20110207799A1 (en) * | 2010-02-24 | 2011-08-25 | Roche Madison Inc. | Compositions for Targeted Delivery of siRNA |
CN103968769A (en) * | 2013-02-04 | 2014-08-06 | 通用汽车环球科技运作有限责任公司 | Method for automatic quantification of dendrite arm spacing in dendritic microstructures |
CN104311830A (en) * | 2014-09-26 | 2015-01-28 | 浙江大学 | Dendritic gene and drug carrier, and preparation and application thereof |
US9023248B2 (en) | 2008-05-28 | 2015-05-05 | University Of Washington | Diels-Alder crosslinkable dendritic nonlinear optic chromophores and polymer composites |
US20180318454A1 (en) * | 2015-11-04 | 2018-11-08 | Duke University | Conjugated polycationic polymers, methods of using the same and methods of treating autoimmune diseases, infectious diseases and acute radiation exposure |
US10232593B2 (en) | 2013-03-13 | 2019-03-19 | The Sherwin-Williams Company | Oxygen-scavenging composition and articles thereof |
CN112011062A (en) * | 2019-05-29 | 2020-12-01 | 彤程新材料集团股份有限公司 | Non-silane polymer coupling agent, preparation method and vulcanizable rubber composition |
CN113201135A (en) * | 2021-04-28 | 2021-08-03 | 吉林大学 | Preparation method and application of active oxygen responsive material PAM-SH |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3485658A (en) * | 1965-07-22 | 1969-12-23 | Du Pont | Plural monolayer coated article and process of making |
US4568737A (en) * | 1983-01-07 | 1986-02-04 | The Dow Chemical Company | Dense star polymers and dendrimers |
US4587329A (en) * | 1984-08-17 | 1986-05-06 | The Dow Chemical Company | Dense star polymers having two dimensional molecular diameter |
US4681799A (en) * | 1984-11-01 | 1987-07-21 | Research Development Corp. Of Japan | Ultrathin polymeric imine films and process for making the same |
US4694064A (en) * | 1986-02-28 | 1987-09-15 | The Dow Chemical Company | Rod-shaped dendrimer |
US4778720A (en) * | 1984-01-11 | 1988-10-18 | Research Dev. Corp. Of Japan | Ultrathin polymeric imine films and process for making the same |
US4847328A (en) * | 1986-08-29 | 1989-07-11 | E. I. Du Pont De Nemours And Company | Hybrid acrylic star polymers |
US4851477A (en) * | 1986-08-29 | 1989-07-25 | E. I. Du Pont De Nemours And Company | Hybrid acrylic-condensation star polymers by group transfer polymerization |
US4941997A (en) * | 1987-07-13 | 1990-07-17 | Ciba-Geigy Corporation | Amphiphilic azo dyes and molecular aggregates thereof |
US4973429A (en) * | 1988-02-17 | 1990-11-27 | Ciba-Geigy Corporation | Organic materials with non-linear optical properties |
US5035763A (en) * | 1987-07-24 | 1991-07-30 | Basf Aktiengesellschaft | Preparation of thin films |
US5035762A (en) * | 1987-07-24 | 1991-07-30 | Basf Aktiengesellschaft | Production of thin films |
US5150446A (en) * | 1991-09-16 | 1992-09-22 | Eastman Kodak Company | Conversion efficiency second harmonic generator |
US5208111A (en) * | 1990-08-25 | 1993-05-04 | Bayer Aktiengesellschaft | One- or multi-layered layer elements applied to supports and their production |
US5247602A (en) * | 1991-09-16 | 1993-09-21 | Eastman Kodak Company | Blue transparent second harmonic generator |
US5731095A (en) * | 1996-10-23 | 1998-03-24 | Oxazogen, Inc. | Dendritic polymer coatings |
US5773527A (en) * | 1990-08-27 | 1998-06-30 | Dendritech, Inc. | Non-crosslinked, polybranched polymers |
-
1997
- 1997-09-30 US US08/941,527 patent/US6020457A/en not_active Expired - Lifetime
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3485658A (en) * | 1965-07-22 | 1969-12-23 | Du Pont | Plural monolayer coated article and process of making |
US4568737A (en) * | 1983-01-07 | 1986-02-04 | The Dow Chemical Company | Dense star polymers and dendrimers |
US4778720A (en) * | 1984-01-11 | 1988-10-18 | Research Dev. Corp. Of Japan | Ultrathin polymeric imine films and process for making the same |
US4587329A (en) * | 1984-08-17 | 1986-05-06 | The Dow Chemical Company | Dense star polymers having two dimensional molecular diameter |
US4966743A (en) * | 1984-11-01 | 1990-10-30 | Research Development Corporation Of Japan | Process for making ultrathin polymeric imine films |
US4681799A (en) * | 1984-11-01 | 1987-07-21 | Research Development Corp. Of Japan | Ultrathin polymeric imine films and process for making the same |
US4694064A (en) * | 1986-02-28 | 1987-09-15 | The Dow Chemical Company | Rod-shaped dendrimer |
US4847328A (en) * | 1986-08-29 | 1989-07-11 | E. I. Du Pont De Nemours And Company | Hybrid acrylic star polymers |
US4851477A (en) * | 1986-08-29 | 1989-07-25 | E. I. Du Pont De Nemours And Company | Hybrid acrylic-condensation star polymers by group transfer polymerization |
US4941997A (en) * | 1987-07-13 | 1990-07-17 | Ciba-Geigy Corporation | Amphiphilic azo dyes and molecular aggregates thereof |
US5068318A (en) * | 1987-07-13 | 1991-11-26 | Ciba-Geigy Corporation | Diamenodinitroazo dyes |
US5035763A (en) * | 1987-07-24 | 1991-07-30 | Basf Aktiengesellschaft | Preparation of thin films |
US5035762A (en) * | 1987-07-24 | 1991-07-30 | Basf Aktiengesellschaft | Production of thin films |
US4973429A (en) * | 1988-02-17 | 1990-11-27 | Ciba-Geigy Corporation | Organic materials with non-linear optical properties |
US5208111A (en) * | 1990-08-25 | 1993-05-04 | Bayer Aktiengesellschaft | One- or multi-layered layer elements applied to supports and their production |
US5773527A (en) * | 1990-08-27 | 1998-06-30 | Dendritech, Inc. | Non-crosslinked, polybranched polymers |
US5150446A (en) * | 1991-09-16 | 1992-09-22 | Eastman Kodak Company | Conversion efficiency second harmonic generator |
US5247602A (en) * | 1991-09-16 | 1993-09-21 | Eastman Kodak Company | Blue transparent second harmonic generator |
US5731095A (en) * | 1996-10-23 | 1998-03-24 | Oxazogen, Inc. | Dendritic polymer coatings |
Non-Patent Citations (19)
Title |
---|
Assembly, Structural Characterization, and Thermal Behavior of Layer by Layer Deposited Ultrathin Films Of Poly(vinyl sulfate) and Poly(allylamine), Yuri Lvov, Gero Decher, and Helmuth Mohwald, Langmuir 1993, 9, 481 486, The month in the date of publication is not available. * |
Assembly, Structural Characterization, and Thermal Behavior of Layer-by-Layer Deposited Ultrathin Films Of Poly(vinyl sulfate) and Poly(allylamine), Yuri Lvov, Gero Decher, and Helmuth Mohwald, Langmuir 1993, 9, 481-486, The month in the date of publication is not available. |
Buildup Of Ultrathin Multilayer Films By A Self Assembly Process, 1 Consecutive Adsorption Of Anionic and Cationic Bipolar Amphiphiles On Charged Surfaces, Gero Decher and Jong Dal Hong, Makromol. Chem. Macromol. Symp. 46, 321 327 (1991), The month in the date of publication is not available. * |
Buildup Of Ultrathin Multilayer Films By A Self Assembly Process: III. Consecutively Alternating Adsorption Of Anionic And Cationic Polyelectrolytes On Charge Surfaces, G. Decher, J.D. Hong and J. Schmitt, Thin Solid Films, 210/211 (1992) 831 8325, The month in the date of publication is not available. * |
Buildup Of Ultrathin Multilayer Films By A Self-Assembly Process, 1 Consecutive Adsorption Of Anionic and Cationic Bipolar Amphiphiles On Charged Surfaces, Gero Decher and Jong-Dal Hong, Makromol. Chem. Macromol. Symp. 46, 321-327 (1991), The month in the date of publication is not available. |
Buildup Of Ultrathin Multilayer Films By A Self-Assembly Process: III. Consecutively Alternating Adsorption Of Anionic And Cationic Polyelectrolytes On Charge Surfaces, G. Decher, J.D. Hong and J. Schmitt, Thin Solid Films, 210/211 (1992) 831-8325, The month in the date of publication is not available. |
Cascade (Starburst ) Dendrimer Synthesis By The Divergent Dendron/Divergent Core Anchoring Methods, Donald A. Tomalia, Douglas R. Swanson, June W. Klimash and Herbert M. Brothers, III pp. 52 53, The date of publication is not available. * |
Cascade (Starburst™) Dendrimer Synthesis By The Divergent Dendron/Divergent Core Anchoring Methods, Donald A. Tomalia, Douglas R. Swanson, June W. Klimash and Herbert M. Brothers, III pp. 52-53, The date of publication is not available. |
Dendrimer and Polystyrene Surfactant Structure At The Air Water Interface, P.M. Saville and J.W. White, C.J. Hawker, K.L. Wooley and J.M.J. Frechet, J. Phys. Chem. 1993, 97, 293 294, The month in the date of publication is not available. * |
Dendrimer and Polystyrene Surfactant Structure At The Air-Water Interface, P.M. Saville and J.W. White, C.J. Hawker, K.L. Wooley and J.M.J. Frechet, J. Phys. Chem. 1993, 97, 293-294, The month in the date of publication is not available. |
Division Of Inorganic Chemistry, Bruce E. Bursten, American Chemical Society, The date of publication is not available. * |
Fine Tuning Of The Film Thickness Of Ultrathin Multilayer Films Composed Of Consecutively Alternating Layers Of Anionic and Cationic Polyelectrolytes, G. Decher and J. Schmitt, Progr. Colloid Polym Sci 89:160 164 (1992), The month in the date of publication is not available. * |
Fine-Tuning Of The Film Thickness Of Ultrathin Multilayer Films Composed Of Consecutively Alternating Layers Of Anionic and Cationic Polyelectrolytes, G. Decher and J. Schmitt, Progr. Colloid Polym Sci 89:160-164 (1992), The month in the date of publication is not available. |
Molecular Monolayers and Films, J.F.Swalen, D.L. Allara, J.D. Andrade, E.A. Chandross, S. Garoff, J. Israelachvili, T.J. McCarthy, R. Murray, R.F. Pease, J.F. Rabolt, K.J. Wynne, and H. Yu, Langmuri 1987, 3, 932 950, The month in the date of publication is not available. * |
Molecular Monolayers and Films, J.F.Swalen, D.L. Allara, J.D. Andrade, E.A. Chandross, S. Garoff, J. Israelachvili, T.J. McCarthy, R. Murray, R.F. Pease, J.F. Rabolt, K.J. Wynne, and H. Yu, Langmuri 1987, 3, 932-950, The month in the date of publication is not available. |
Molecular Self Assembly Of Conducting Polymers: A New Layer by Layer Thin Film Deposition Process, J.H. Cheung, A.F. Fou, M. Ferreira and M.F. Rubner, Dept. of Materials Science and Engineering, pp. 757 758, The date of publication is not available. * |
Molecular Self-Assembly Of Conducting Polymers: A New Layer-by-Layer Thin Film Deposition Process, J.H. Cheung, A.F. Fou, M. Ferreira and M.F. Rubner, Dept. of Materials Science and Engineering, pp. 757-758, The date of publication is not available. |
Starburst Dendrimers: Molecular Level Control Of Size, Shape, Surface Chemistry, Topology, and Flexibility Form Atoms To Macroscopic Matter, Donald A. Tomalia, Adel M. Naylor and William A. Goddard III, Angew. Chem. Int. Ed. Engl. 29 (1990) 138 175, The month in the date of publication is not available. * |
Starburst Dendrimers: Molecular-Level Control Of Size, Shape, Surface Chemistry, Topology, and Flexibility Form Atoms To Macroscopic Matter, Donald A. Tomalia, Adel M. Naylor and William A. Goddard III, Angew. Chem. Int. Ed. Engl. 29 (1990) 138-175, The month in the date of publication is not available. |
Cited By (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6475495B1 (en) * | 1997-12-19 | 2002-11-05 | L'oreal, S.A. | Hyperbranched polymers or dendrimers containing a particular group, preparation process, use and compositions comprising them |
US6432423B1 (en) * | 1997-12-19 | 2002-08-13 | L'oreal | Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
US9096898B2 (en) | 1998-05-01 | 2015-08-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9212393B2 (en) | 1998-05-01 | 2015-12-15 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US20110183321A1 (en) * | 1998-05-01 | 2011-07-28 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
US9957561B2 (en) | 1998-05-01 | 2018-05-01 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US7645596B2 (en) | 1998-05-01 | 2010-01-12 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US10208341B2 (en) | 1998-05-01 | 2019-02-19 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US20050032076A1 (en) * | 1998-05-01 | 2005-02-10 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
US10214774B2 (en) | 1998-05-01 | 2019-02-26 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9725764B2 (en) | 1998-05-01 | 2017-08-08 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9458500B2 (en) | 1998-05-01 | 2016-10-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9540689B2 (en) | 1998-05-01 | 2017-01-10 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US20080281041A1 (en) * | 1999-06-07 | 2008-11-13 | Rozema David B | Reversibly Masked Polymers |
US10022456B2 (en) | 1999-06-07 | 2018-07-17 | Arrowhead Pharmaceuticals, Inc. | Reversibly masked polymers |
US20080281074A1 (en) * | 1999-06-07 | 2008-11-13 | Rozema David B | Compounds and Methods for Reversible Modification of Biologically Active Molecules |
US8541548B2 (en) | 1999-06-07 | 2013-09-24 | Arrowhead Madison Inc. | Compounds and methods for reversible modification of biologically active molecules |
US20020025529A1 (en) * | 1999-06-28 | 2002-02-28 | Stephen Quake | Methods and apparatus for analyzing polynucleotide sequences |
US6818395B1 (en) | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
US20050014175A1 (en) * | 1999-06-28 | 2005-01-20 | California Institute Of Technology | Methods and apparatuses for analyzing polynucleotide sequences |
US20060019263A1 (en) * | 1999-06-28 | 2006-01-26 | Stephen Quake | Methods and apparatuses for analyzing polynucleotide sequences |
US20050147992A1 (en) * | 1999-06-28 | 2005-07-07 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
US7501245B2 (en) | 1999-06-28 | 2009-03-10 | Helicos Biosciences Corp. | Methods and apparatuses for analyzing polynucleotide sequences |
US6911345B2 (en) | 1999-06-28 | 2005-06-28 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
US6773928B1 (en) * | 1999-09-22 | 2004-08-10 | The United States Of America As Represented By The Secretary Of The Army | Compositions and methods for enhancing bioassay performance |
US20040146918A1 (en) * | 2000-02-18 | 2004-07-29 | Weiner Michael L. | Hybrid nucleic acid assembly |
US20080280353A1 (en) * | 2000-02-18 | 2008-11-13 | Biomed Solutions Llc | Hybrid nucleic acid assembly |
US20030183578A1 (en) * | 2000-07-28 | 2003-10-02 | Kim Yung K. | Silicone derivatized macromolecules |
US20060237365A1 (en) * | 2000-07-28 | 2006-10-26 | Diazem Corporation | Silicone derivatized macromolecules |
US6889735B2 (en) | 2000-08-03 | 2005-05-10 | The Goodyear Tire & Rubber Company | Pneumatic tire having a rubber component containing a dendrimer |
US20040020576A1 (en) * | 2000-08-03 | 2004-02-05 | The Goodyear Tire & Rubber Company | Pneumatic tire having a rubber component containing a dendrimer |
US20030082103A1 (en) * | 2000-10-11 | 2003-05-01 | Targesome, Inc. | Targeted therapeutic lipid constructs having cell surface targets |
US20030129223A1 (en) * | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
US20030133972A1 (en) * | 2000-10-11 | 2003-07-17 | Targesome, Inc. | Targeted multivalent macromolecules |
WO2002067908A1 (en) * | 2001-02-26 | 2002-09-06 | Duke University | Novel dendritic polymers and their biomedical uses |
WO2002072892A1 (en) * | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
US20030119208A1 (en) * | 2001-12-04 | 2003-06-26 | Yoon Hyun Chul | Electrochemical immunosensor and kit and method for detecting biochemical anylyte using the sensor |
US20040009495A1 (en) * | 2001-12-07 | 2004-01-15 | Whitehead Institute For Biomedical Research | Methods and products related to drug screening using gene expression patterns |
US6617040B2 (en) | 2002-01-16 | 2003-09-09 | The United States Of America As Represented By The Secretary Of The Navy | Chemoselective dendrimeric compounds for use in chemical sensors |
US20040131582A1 (en) * | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
US20090048410A1 (en) * | 2002-03-11 | 2009-02-19 | Wakefield Darren H | Membrane Active Heteropolymers |
US20080287628A1 (en) * | 2002-03-11 | 2008-11-20 | Rozema David B | Endosomolytic Poly(Vinyl Ether) Polymers |
US8008355B2 (en) | 2002-03-11 | 2011-08-30 | Roche Madison Inc. | Endosomolytic poly(vinyl ether) polymers |
US8138383B2 (en) | 2002-03-11 | 2012-03-20 | Arrowhead Madison Inc. | Membrane active heteropolymers |
WO2003089106A2 (en) | 2002-04-16 | 2003-10-30 | Diazem Corporation | Multi-layered macromolecules and methods for their use |
EP1503836A2 (en) * | 2002-04-16 | 2005-02-09 | Diazem Corporation | Multi-layered macromolecules and methods for their use |
EP1503836A4 (en) * | 2002-04-16 | 2005-06-15 | Diazem Corp | Multi-layered macromolecules and methods for their use |
US7862807B2 (en) | 2002-07-19 | 2011-01-04 | University Of California, San Diego | Dendrimers as molecular translocators |
US20060216265A1 (en) * | 2002-07-19 | 2006-09-28 | The Regents Of The University Of California | Dendrimers as molecular translocators |
US20080221020A1 (en) * | 2002-07-19 | 2008-09-11 | The Regents Of The University Of California | Dendrimers as Molecular Translocators |
US20050247911A1 (en) * | 2002-08-29 | 2005-11-10 | Burn Paul L | Blended dendrimers |
WO2004020504A1 (en) * | 2002-08-29 | 2004-03-11 | Isis Innovation Limited | Blended dendrimers |
US7977861B2 (en) | 2002-08-29 | 2011-07-12 | Isis Innovation Limited | Blended dendrimers |
US6733883B2 (en) | 2002-09-18 | 2004-05-11 | The Trustees Of The University Of Pennsylvania | Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
US20040063158A1 (en) * | 2002-09-26 | 2004-04-01 | Ivan Alferiev | Method of determining surface binding capacity |
US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
US20040258614A1 (en) * | 2003-06-20 | 2004-12-23 | University Of Maryland, Baltimore | Microparticles for microarterial imaging and radiotherapy |
US20060177376A1 (en) * | 2003-07-21 | 2006-08-10 | Dendritic Nanotechnologies, Inc. | Stabilized and chemically functionalized nanoparticles |
WO2005029539A3 (en) * | 2003-07-21 | 2005-05-06 | Dendritic Nanotechnologies Inc | Stabilized and chemically functionalized nanoparticles |
US7897345B2 (en) | 2003-11-12 | 2011-03-01 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US20110152114A1 (en) * | 2003-11-12 | 2011-06-23 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US9012144B2 (en) | 2003-11-12 | 2015-04-21 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
US9657344B2 (en) | 2003-11-12 | 2017-05-23 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
US20060041058A1 (en) * | 2003-11-21 | 2006-02-23 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US8597653B2 (en) | 2003-11-21 | 2013-12-03 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US20110065090A1 (en) * | 2003-11-21 | 2011-03-17 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US20110053243A1 (en) * | 2003-11-21 | 2011-03-03 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US20110053175A1 (en) * | 2003-11-21 | 2011-03-03 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US8591904B2 (en) | 2003-11-21 | 2013-11-26 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US7754500B2 (en) | 2003-11-21 | 2010-07-13 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US8501399B2 (en) | 2003-11-21 | 2013-08-06 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US20060172408A1 (en) * | 2003-12-01 | 2006-08-03 | Quake Steven R | Device for immobilizing chemical and biochemical species and methods of using same |
US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
US20060046258A1 (en) * | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
US20060078927A1 (en) * | 2004-03-29 | 2006-04-13 | Peck Bill J | Methods for in situ generation of nucleic acid molecules |
US20050239085A1 (en) * | 2004-04-23 | 2005-10-27 | Buzby Philip R | Methods for nucleic acid sequence determination |
US20050260609A1 (en) * | 2004-05-24 | 2005-11-24 | Lapidus Stanley N | Methods and devices for sequencing nucleic acids |
US20060019276A1 (en) * | 2004-05-25 | 2006-01-26 | Timothy Harris | Methods and devices for nucleic acid sequence determination |
US20060088499A1 (en) * | 2004-07-01 | 2006-04-27 | Virgil Percec | Amphiphilic dendritic dipeptides & their self-assembly into helical pores |
US7671033B2 (en) | 2004-07-01 | 2010-03-02 | The Trustees Of The University Of Pennsylvania | Amphiphilic dendritic dipeptides and their self-assembly into helical pores |
US20060024678A1 (en) * | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
US20060223195A1 (en) * | 2004-11-16 | 2006-10-05 | Meyer Grant D | Stress based removal of nonspecific binding from surfaces |
US20060118754A1 (en) * | 2004-12-08 | 2006-06-08 | Lapen Daniel C | Stabilizing a polyelectrolyte multilayer |
US20060217525A1 (en) * | 2004-12-22 | 2006-09-28 | Wright Davis Biomedical Technologies, Inc. | Degradable polymers and methods of preparation thereof |
US20060252077A1 (en) * | 2004-12-30 | 2006-11-09 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
US20060172328A1 (en) * | 2005-01-05 | 2006-08-03 | Buzby Philip R | Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction |
US20060172313A1 (en) * | 2005-01-28 | 2006-08-03 | Buzby Philip R | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
US20080114077A1 (en) * | 2005-03-21 | 2008-05-15 | Anp Technologies, Inc. | Symmetrically Branched Polymer Conjugates and Microarray Assays |
US7977452B2 (en) * | 2005-03-28 | 2011-07-12 | Dendritic Nanotechnologies, Inc. | Janus dendrimers and dendrons |
US20080221300A1 (en) * | 2005-03-28 | 2008-09-11 | Tomalia Donald A | Janus Dendrimers and Dendrons |
WO2006105043A3 (en) * | 2005-03-28 | 2007-10-04 | Dendritic Nanotechnologies Inc | Janus dendrimers and dendrons |
US9176142B2 (en) | 2005-05-02 | 2015-11-03 | Anp Technologies, Inc. | Polymer conjugate enhanced bioassays |
US20080200562A1 (en) * | 2005-05-02 | 2008-08-21 | Anp Technologies | Polymer Conjugate Enhanced Bioassays |
US8563329B2 (en) | 2005-05-02 | 2013-10-22 | Anp Technologies, Inc. | Polymer conjugate enhanced bioassays |
US20060263790A1 (en) * | 2005-05-20 | 2006-11-23 | Timothy Harris | Methods for improving fidelity in a nucleic acid synthesis reaction |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
US9868978B2 (en) | 2005-08-26 | 2018-01-16 | Fluidigm Corporation | Single molecule sequencing of captured nucleic acids |
US20070117102A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070117103A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070117104A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
US20070128614A1 (en) * | 2005-12-06 | 2007-06-07 | Liu David R | Nucleotide analogs |
KR100745833B1 (en) | 2006-03-06 | 2007-08-02 | 고려대학교 산학협력단 | Complex composition of cationic gold nanoparticles and dna for effective transfection |
US7579420B2 (en) | 2006-04-04 | 2009-08-25 | E. I. Du Pont De Nemours And Company | Hyperbranched maleic anhydride-diene polymers |
US7833585B2 (en) | 2006-04-04 | 2010-11-16 | E.I. Du Pont De Nemours And Company | Hyperbranched maleic anhydride-diene polymers |
US7790822B2 (en) | 2006-04-04 | 2010-09-07 | E.I. Du Pont De Nemours And Company | Hyperbranched maleic anhydride-diene polymers |
US7579403B2 (en) | 2006-04-04 | 2009-08-25 | E. I. Du Pont De Nemours And Company | Stain resist comprising hyperbranched maleic anhydride-diene polymers |
US20070232770A1 (en) * | 2006-04-04 | 2007-10-04 | Jacobson Stephen E | Hyperbranched maleic anhydride-diene polymers |
US20070226915A1 (en) * | 2006-04-04 | 2007-10-04 | Jacobson Stephen E | Stain resist comprising hyperbranched maleic anhydride-diene polymers |
US20080020043A1 (en) * | 2006-07-20 | 2008-01-24 | Marc Gingras | Dendrimer-Drug Conjugates |
US8137695B2 (en) | 2006-08-18 | 2012-03-20 | Arrowhead Madison Inc. | Polyconjugates for in vivo delivery of polynucleotides |
US7985406B2 (en) | 2006-08-18 | 2011-07-26 | Roche Madison Inc. | Membrane active heteropolymers |
US20090023890A1 (en) * | 2006-08-18 | 2009-01-22 | Monahan Sean D | Membrane Active Heteropolymers |
US20080152661A1 (en) * | 2006-08-18 | 2008-06-26 | Rozema David B | Polyconjugates for In Vivo Delivery of Polynucleotides |
US8404223B2 (en) * | 2006-09-29 | 2013-03-26 | The University Of Nottingham | Polymer |
US20100028445A1 (en) * | 2006-09-29 | 2010-02-04 | The University Of Nottingham | Polymer |
AU2007301693B2 (en) * | 2006-09-29 | 2014-01-23 | The University Of Milan | Polymer |
US20100105857A1 (en) * | 2006-10-16 | 2010-04-29 | Gary Gellerman | Dendrimeric platform for controlled release of drugs |
US8431543B2 (en) | 2007-01-05 | 2013-04-30 | Engene, Inc | Chitosan based polymer conjugate and a method for producing the same |
US20100113559A1 (en) * | 2007-01-05 | 2010-05-06 | Biopolymed Inc. | Chitosan Based Polymer Conjugate and a Method for Producing the Same |
US8476400B2 (en) | 2007-08-27 | 2013-07-02 | Valspar Sourcing, Inc. | Dendritic oxygen scavenging polymer |
US8871352B2 (en) | 2007-08-27 | 2014-10-28 | Valspar Sourcing, Inc. | Dendritic oxygen scavenging polymer |
US20110111951A1 (en) * | 2007-08-27 | 2011-05-12 | Valspar Sourcing, Inc. | Dendritic Oxygen Scavenging Polymer |
US9023248B2 (en) | 2008-05-28 | 2015-05-05 | University Of Washington | Diels-Alder crosslinkable dendritic nonlinear optic chromophores and polymer composites |
US8153729B2 (en) | 2008-05-29 | 2012-04-10 | The Regents Of The University Of California | Highly efficient agents for dispersion of nanoparticles in matrix materials |
US20090299003A1 (en) * | 2008-05-29 | 2009-12-03 | Hawker Craig J | Highly efficient agents for dispersion of nanoparticles in matrix materials |
WO2009148712A1 (en) * | 2008-05-29 | 2009-12-10 | The Regents Of The University Of California | Highly efficient agents for dispersion of nanoparticles in matrix materials |
WO2010033137A1 (en) * | 2008-09-19 | 2010-03-25 | Trustees Of Boston University | Polymeric biolubricants for medical use |
WO2011065916A1 (en) * | 2009-11-24 | 2011-06-03 | Agency For Science, Technology And Research | Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel |
US8796234B2 (en) | 2009-11-24 | 2014-08-05 | Agency For Science, Technology And Research | Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel |
US20110207799A1 (en) * | 2010-02-24 | 2011-08-25 | Roche Madison Inc. | Compositions for Targeted Delivery of siRNA |
US8313772B2 (en) | 2010-02-24 | 2012-11-20 | Arrowhead Madison Inc. | Compositions for targeted delivery of siRNA |
US10316316B2 (en) | 2010-02-24 | 2019-06-11 | Arrowhead Pharmaceuticals, Inc. | Compositions for targeted delivery of siRNA |
US9345775B2 (en) | 2010-02-24 | 2016-05-24 | Arrowhead Madison Inc. | Compositions for targeted delivery of siRNA |
CN103968769B (en) * | 2013-02-04 | 2017-06-06 | 通用汽车环球科技运作有限责任公司 | For the automatic method for quantifying dendritic arm spacing in dendrite microstructure |
CN103968769A (en) * | 2013-02-04 | 2014-08-06 | 通用汽车环球科技运作有限责任公司 | Method for automatic quantification of dendrite arm spacing in dendritic microstructures |
US10232593B2 (en) | 2013-03-13 | 2019-03-19 | The Sherwin-Williams Company | Oxygen-scavenging composition and articles thereof |
CN104311830A (en) * | 2014-09-26 | 2015-01-28 | 浙江大学 | Dendritic gene and drug carrier, and preparation and application thereof |
CN104311830B (en) * | 2014-09-26 | 2017-02-22 | 浙江大学 | Dendritic gene and drug carrier, and preparation and application thereof |
US20180318454A1 (en) * | 2015-11-04 | 2018-11-08 | Duke University | Conjugated polycationic polymers, methods of using the same and methods of treating autoimmune diseases, infectious diseases and acute radiation exposure |
CN112011062A (en) * | 2019-05-29 | 2020-12-01 | 彤程新材料集团股份有限公司 | Non-silane polymer coupling agent, preparation method and vulcanizable rubber composition |
US11274188B2 (en) * | 2019-05-29 | 2022-03-15 | Red Avenue New Materials Group Co., Ltd. | Non-silane polymeric coupler |
CN112011062B (en) * | 2019-05-29 | 2022-06-24 | 彤程新材料集团股份有限公司 | Non-silane polymer coupling agent, preparation method and vulcanizable rubber composition |
CN113201135A (en) * | 2021-04-28 | 2021-08-03 | 吉林大学 | Preparation method and application of active oxygen responsive material PAM-SH |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6020457A (en) | Disulfide-containing dendritic polymers | |
Nijhuis et al. | Multivalent dendrimers at molecular printboards: influence of dendrimer structure on binding strength and stoichiometry and their electrochemically induced desorption | |
Harada et al. | Polymeric rotaxanes | |
Thompson et al. | Synthesis and applications of heterobifunctional poly (ethylene oxide) oligomers | |
Zeng et al. | Dendrimers in supramolecular chemistry: from molecular recognition to self-assembly | |
Chapman et al. | Preparation of mixed self-assembled monolayers (SAMs) that resist adsorption of proteins using the reaction of amines with a SAM that presents interchain carboxylic anhydride groups | |
Mazzotta et al. | Electrochemical sensing of macromolecules based on molecularly imprinted polymers: challenges, successful strategies, and opportunities | |
CA2163519C (en) | Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands | |
DE69620898T2 (en) | INTERACTIVE MOLECULAR CONJUGATES | |
Thomas et al. | Solid-state nanostructured materials from self-assembly of a globular protein–polymer diblock copolymer | |
Cao et al. | Controlled DNA patterning by chemical lift-off lithography: Matrix matters | |
Coffer | Semiconducting silicon nanowires for biomedical applications | |
US20100059391A1 (en) | Method for detecting biomolecules and use thereof | |
WO2008028206A2 (en) | Method for producing reactive monolayer units | |
EP1279959A1 (en) | Polymer composition for forming surface of biosensor | |
Akiyama et al. | Synthesis of heterotelechelic poly (ethylene glycol) derivatives having α-benzaldehyde and ω-pyridyl disulfide groups by ring opening polymerization of ethylene oxide using 4-(diethoxymethyl) benzyl alkoxide as a novel initiator | |
Rastogi et al. | Preventing nonspecific adsorption on polymer brush covered gold electrodes using a modified ATRP initiator | |
Patle et al. | The advanced synthetic modifications and applications of multifunctional PAMAM dendritic composites | |
Shuster et al. | Comparison of Oligo (ethylene glycol) alkanethiols versus n-Alkanethiols: Self-Assembly, Insertion, and Functionalization | |
EP1644527B9 (en) | Cucurbituril derivative-bonded solid substrate and biochip using the same | |
SG172498A1 (en) | Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors | |
Swiech et al. | PEGylated Network Nanostructured by Gold Nanoparticles for Electrochemical Sensing of Aromatic Redox and Nonredox Analytes | |
US11899012B2 (en) | Single-chain polymer-based target receptors for use in electrochemical detection of target analytes | |
JPWO2003076933A1 (en) | Brushed surface of increased density poly (ethylene oxide) | |
Sarkar et al. | Probing Polymer Chain Folding in Solution Using Second Harmonic Light Scattering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DENDRITECH, INC., MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KLIMASH, JUNE W.;BROTHERS, HERBERT M. II;SWANSON, DOUGLAS R.;AND OTHERS;REEL/FRAME:010105/0037;SIGNING DATES FROM 19971002 TO 19971029 |
|
AS | Assignment |
Owner name: TOMALIA, DONALD A., MICHIGAN Free format text: RIGHT TO RECEIVE ROYALTIES;ASSIGNORS:MICHIGAN MOLECULAR INSTITUTE;DENDRITECH INCORPORATED;REEL/FRAME:010281/0183 Effective date: 19990501 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: DOW CHEMICAL COMPANY, THE, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DENDRITECH, INC.;REEL/FRAME:010961/0555 Effective date: 20000313 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REFU | Refund |
Free format text: REFUND - SURCHARGE, PETITION TO ACCEPT PYMT AFTER EXP, UNINTENTIONAL (ORIGINAL EVENT CODE: R2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: AVC HOLDINGS INC., MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DOW CHEMICAL COMPANY, THE;REEL/FRAME:016800/0047 Effective date: 20050201 |
|
AS | Assignment |
Owner name: DENDRITIC NANOTECHNOLOGIES. INC., MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVX HOLDINGS, INC.;REEL/FRAME:017125/0378 Effective date: 20050215 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |